fda glp-1 compounding enforcement november 2025 news semaglutide The FDA has released new guidance for providers prescribing GLP-1 Shortage = Over Safe use of compounded GLP

We have fun as we get stuff done, and we celebrate together

The prescribing information reports a greater distribution of improvement among tesamorelin-treated participants compared with placebo. A separate analysis reported improvements in body-image distress alongside reductions in visceral adipose tissue. Why it matters Patient-reported outcomes provide information that imaging and laboratory measurements cannot capture

Im very pleased with the Botox I received with Dr

Common mistakes to avoid with sermorelin therapy Properly administering sermorelin therapy is key to its success and safety

However, it's important to note that measuring total glutathione levels in the blood might not fully represent the amount of active or functional glutathione within cells